Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Ocular inflammatory manifestations in patients with rheumatoid arthritis
Raul E. Ruiz-Lozano; Luis Arnaldo Prida-Espaillat; Reinaldo A. Moll-Auais; Eugenia M. Ramos-Dávila; Manuel E. Quiroga-Garza; Aaron Zhao; Ali Khodor; Amr Almobayed; David Vega-Morales; Alejandro Rodriguez-Garcia;
Reumatol Clin. 2025;21:
JAK kinase inhibitors and varicella zoster virus infection in patients with rheumatoid arthritis. Systematic review of the literature
Carmen Olga Sánchez González; Juan Carlos Nieto González;
Reumatol Clin. 2022;18:453-8